Myriad Genetics entered into an agreement with CancerCARE for Life to provide individuals within the latter's network with access to the MyRisk Hereditary Cancer Test.

A NEW study has demonstrated that AI can be used alongside mammography to effectively identify women at high risk of breast ...

A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...

Vicky Tennant has followed official advice and had a mammogram every two years. Now in her 70s, the Sydney woman believed she ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...

The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in ...

Significant increases in breast cancer incidence were found among Hispanic, American Indian or Alaska Native, and Asian or ...

HER2-positive (HER2+) breast cancer treatments come with a range of unpleasant side effects. However, there are strategies ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.